Phibro Animal Health Corporation Class A Forecast, price target & analysts
Phibro Animal Health Corporation Class A Target price 2025 - Analyst rating & recommendation
Phibro Animal Health Corporation Class A Classifications & Recommendation:
Phibro Animal Health Corporation Class A Price Target
| Target Price | $21.00 |
| Price | $22.45 |
| Deviation |
6.46%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Phibro Animal Health Corporation Class A 2026 .
The average Phibro Animal Health Corporation Class A target price is $21.00.
This is
6.46%
register free of charge
$27.00
20.27%
register free of charge
$9.00
59.91%
register free of charge
|
|
| A rating was issued by 5 analysts: 0 Analysts recommend Phibro Animal Health Corporation Class A to buy, 2 to hold and 3 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Phibro Animal Health Corporation Class A stock has an average upside potential 2026 of
6.46%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Jun '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion $ | 1.02 | 1.21 |
| 4.07% | 19.15% | |
| EBITDA Margin | 9.69% | 14.07% |
| 16.88% | 45.22% | |
| Net Margin | 0.24% | 3.22% |
| 92.88% | 1,248.53% |
4 Analysts have issued a sales forecast Phibro Animal Health Corporation Class A 2025 . The average Phibro Animal Health Corporation Class A sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Phibro Animal Health Corporation Class A EBITDA forecast 2025. The average Phibro Animal Health Corporation Class A EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
3 Phibro Animal Health Corporation Class A Analysts have issued a net profit forecast 2025. The average Phibro Animal Health Corporation Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Jun '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.06 | 0.96 |
| 92.59% | 1,500.00% | |
| P/E | 23.30 | |
| EV/Sales | 1.35 |
3 Analysts have issued a Phibro Animal Health Corporation Class A forecast for earnings per share. The average Phibro Animal Health Corporation Class A <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Phibro Animal Health Corporation Class A stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Phibro Animal Health Corporation Class A...
Current Phibro Animal Health Corporation Class A Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Barclays |
Locked
➜
Locked
|
Locked | Feb 10 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 17 2024 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 12 2024 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Sep 10 2024 |
| B of A Securities |
Locked
➜
Locked
|
Locked | Aug 30 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Barclays:
Locked
➜
Locked
|
Feb 10 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 17 2024 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 12 2024 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Sep 10 2024 |
|
Locked
B of A Securities:
Locked
➜
Locked
|
Aug 30 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
